Immunoglobulins Depleted Serum

Added to your cart

Immunoglobulins Depleted Serum

Cart subtotal: £0.00

View cart (0) Checkout

#SKU SF505-2

£157.84

Price excludes shipping costs.
To view our shipping costs click here.

Need to order this product in bulk?

Contact our team of experts to discuss your bulk requirements

Contact our expert team

Product Details

Pooled normal human off the clot serum which is depleted IgE, IgD, IgG, IgA and IgM with the total protein returned to the normal range. Serum is diafiltered into a HEPES buffer and filtered to 0.2µm for optimal product clarity. Immunoglobulin depleted serum can be used as a negative base for all serological assay formats
10ml
SF505-2

More information

Attributes

Description

  • Shipping Information
  • Dry Ice
  • Abbreviations
  • Total Ig depl. serum
  • Specification
  • ≤5 g/L IgG,≤0.4 g/L IgA, ≤0.2 g/L IgM, ≤5 IU/ml IgE, ≤20 U/ml IgD
  • Recommended Use
  • Research and further manufacturing
  • Preservatives
  • N/A
  • Buffer
  • 10mM HEPES, pH 7.5 containing 0.15M NaCl
  • Disease Area
  • Autoimmunity and inflammation
  • Presentation Matrix
  • Frozen liquid Immunoglobulin depleted and dialysed into 10mM HEPES, pH 7.5 containing 0.15M NaCl, filtered through 0.2µm membrane
  • Source
  • Human Serum

Technical Documents

Certificates Of Analysis (125.46KB)

Sorry, no results found.

Enter the full lot number and hit enter.

BBI Solutions Brands

diarect.png

The acquisition of DIARECT in June 2020 and their world leading recombinant autoimmune antigen capability immediately enhances BBI’s portfolio and position as a ‘complete’ immunoassay reagent supplier. This further enhances BBI’s position as the world’s largest diagnostics components company with a market leading antigen portfolio.

mbs.png

Maine Biotechnology Services brings 27 years of knowledge, experience, process development, and project management to our customers to ensure the best possible antibodies for any application. As antibody development goals in the biotechnology and pharmaceutical industry have evolved the acquisition of MBS will help BBI further meet and exceed our customers needs.

Newsletter

Signup for our newsletter to receive the latest BBI Solutions updates and special offers in your inbox